Top Japanese Stocks To Invest In Right Now

Ultra-high definition is the next step in television's evolution. 4K TVs ��sets capable of four times the resolution of 1080p ��first hit the market around this time last year, and have continued to increase in both relevance and recognition worldwide.

While U.K. media group BSkyB has expressed cautious optimism that 4K broadcasting may be possible in just a few years' time, South Korea's consumer electronics giants are even further ahead of the curve ��initial tests of 4K broadcasts began earlier this summer, sponsored by LG.

The race is on, but one country is running on an entirely different track. In June, more than 20 competing Japanese manufacturers and broadcasters ��including Sony, Sharp, Toshiba, Panasonic, NTV and the NHK ��put aside their differences and joined forces in a government-backed collaborative forum called "NexTV-F."

Top 5 International Companies To Own In Right Now: American States Water Co (AWR)

American States Water Company (AWR), incorporated on February 25, 1998, is the parent company of Golden State Water Company (GSWC) and American States Utility Services, Inc. (ASUS) and its subsidiaries (Fort Bliss Water Services Company (FBWS), Terrapin Utility Services, Inc. (TUS), Old Dominion Utility Services, Inc. (ODUS), Palmetto State Utility Services, Inc. (PSUS) and Old North Utility Services, Inc. (ONUS)). AWR operates in three segments: water, electric and contracted services. Within the segments, AWR has two principal business units, water and electric service utility operations, conducted through GSWC, and contracted services conducted through ASUS and its subsidiaries.

GSWC is a California public utility company engaged principally in the purchase, production and distribution of water in 75 communities in 10 counties in the State of California. GSWC also provides electric service to the City of Big Bear Lake and surrounding areas in San Bernardino County, California through its Bear Valley Electric Service (BVES) division. GSWC served 255,657 water customers and 23,379 electric customers as of December 31, 2012. ASUS, through its wholly owned subsidiaries, has contracted with the United States government to provide water and/or wastewater services at various military installations, including the operation, maintenance, renewal and replacement of the water and/or wastewater systems, pursuant to 50-year firm, fixed-price contracts. As of December 31, 2012, GSWC�� physical properties consisted of water transmission and distribution systems which included 2,786 miles of pipeline together with services, meters and fire hydrants and approximately 425 parcels of land.

As of December 31, 2012, GSWC owned 244 wells, of which 188 are active operable wells equipped with pumps with an aggregate production capacity of approximately 202.7 million gallons per day. GSWC has 63 connections to the water distribution facilities of the Metropolitan Water District of Southern Cali! fornia (MWD), and other municipal water agencies. GSWC�� storage reservoirs and tanks have an aggregate capacity of approximately 111 million gallons. GSWC owns no dams. GSWC�� electric properties are located in the Big Bear area of San Bernardino County, California. As of December 31, 2012, GSWC owned and operated 29.6 miles of overhead 34.5 kilovolt transmission lines, 1.4 mile of underground 34.5 kilovolt transmission lines, 179.6 miles of 4.16 kilovolt or 2.4 kilovolt distribution lines, 53.2 miles of underground cable, 13 sub-stations and a natural gas-fueled 8.4 megawatt peaking generation facility. GSWC also has franchises, easements and other rights of way for the purpose of constructing and using poles, wires and other appurtenances for transmitting electricity.

Advisors' Opinion:

• [By Insider Monkey]

  American States Water (AWR), meanwhile, is another dividend giant that has seen bullish insider activity of late. The Western US-focused water utilities company has raised dividends in 59 straight years and currently offers a yield of 2.9%. Somewhat astoundingly, American's payout ratio (47%) is still below its industry's average (59%), so the dividend growth doesn't look set to end anytime soon.

Top Japanese Stocks To Invest In Right Now: Emulex Corp (ELX)

Emulex Corporation (Emulex) is a provider of a range of network convergence solutions that connect servers, storage, and networks within the data center. The Company�� product portfolio includes Host Bus Adapters (HBAs), Converged Network Adapters (CNAs), Network Interface Cards (NICs), mezzanine cards for blade servers, Application Specific Integrated Circuits (ASICs), embedded storage bridges, routers, and switches, Input/Output Controllers (IOCs), and connectivity management solutions. The Company is a designer, developer and supplier of HBAs, CNAs, NICs, mezzanine cards, Pass-Through Modules (PTM), embedded storage switches, embedded bridges, embedded routers, I/O ASICs, switch-on-a-chip (SOC) ASICs, Internet Baseboard management controllers (iBMC��) and connectivity management solutions. On August 25, 2010, Emulex acquired ServerEngines Corporation. In February 2013, Emulex acquired 89% ownership of Endace Ltd. In April 2013, Emulex Corp announced the completion of acquisition of Endace Limited.

Host Server Products

The Company�� Host Server Products include the development of chip level and board level server-based I/O adapters, including HBAs, Universal Converged Network Adapters (UCNAs), and mezzanine cards that connect servers and storage to networks using a range of products. Its products support Internet protocol (IP) and storage networking, including transmission control protocol (TCP)/IP, Internet small computer system interface (iSCSI), network attached storage (NAS), Fibre Channel, and Fibre Channel over Ethernet (FCoE). Host Server Products (HSP) include LightPulse HBAs, OneConnecttm UCNAs, custom form factor solutions for original equipment manufacturer (OEM) blade servers, and ASICs. These products enable servers to connect to local area networks (LANs), storage area networks (SANs), and NAS by offloading data communication processing tasks from the server as information is delivered and sent to the network.

Its Fibre Channel H! BAs connect host computers to a Fibre Channel network. The Company�� adapters support a range of operating systems and host computer system interfaces, including Peripheral Component Interconnect (PCI) and PCI Express-based platforms. Its Fibre Channel HBA offerings include single, dual, and quad port adapters at throughput speeds of two gigabyte per second, four gigabyte per second, and eight gigabyte per second for use in enterprise, large, medium, and small-sized organizations. The Emulex OneConnect UCNA is a single chip 10 gigabyte per second Ethernet platform designed to address the challenges of data center networks. The Emulex UCNA platform enables data center managers to consolidate multiple one gigabyte per second Ethernet links on to a single 10 gigabyte per second Ethernet link. Emulex HBAs and UCNAs are based upon its internally developed Fibre Channel and Ethernet IOCs. In addition, these IOCs can be used in embedded I/O environments, such as disk and tape storage arrays and storage appliances. Revenues from these applications are included in the Company�� Embedded Storage Products.

Embedded Storage Products

The Company�� Embedded Storage Products include the development of chip level, board level, and box level array based products that are deployed inside storage arrays, tape libraries, and other storage products to provide connectivity and protocol emulation functions. These products include embedded IOCs, I/O Processors (IOPs), SOCs, embedded bridges (FC/SATA/SAS), and embedded routers (FC/SATA/SAS). Emulex offers a range of integrated, embedded storage networking products for enterprise storage systems that deliver improved performance, reliability and storage connectivity. InSpeed is an advanced switching architecture that results in a single chip capable of handling multiple Fibre Channel devices operating at two, four, or eight gigabyte per second speeds. Its embedded router and bridge products consist of chip and firmware solutions.

! The Compa! ny competes with QLogic Corporation, Brocade Communications Systems, Inc., Broadcom Corporation, Intel Corporation, Chelsio Communications, Inc., Mellanox Technologies, Ltd., LSI, Marvell Technology Group Ltd., Maxim Integrated Products, Inc. and PMC-Sierra, Inc.

Advisors' Opinion:

• [By John Udovich]

  Mid cap networking solutions company Brocade Communications Systems, Inc (NASDAQ: BRCD) has pretty much been a sleeper for investors since the dot.com bust, but that has changed over the past year���meaning its worth revisiting the stock along with potential performance benchmarks�like QLogic Corporation (NASDAQ: QLGC), Emulex Corporation (NYSE: ELX) and iShares North American Tech-Multimedia Networking ETF (NYSEARCA: IGN). I should mention that we have recently Brocade Communications Systems to our SmallCap Network Elite Opportunity (SCN EO) portfolio because the company has successfully transitioned from being a hardware company to supporting virtual networks via software and it continues to offer best-of-breed technology.

• [By Eric Volkman]

  A top-level promotion has taken place at Emulex (NYSE: ELX  ) . The company announced that it has appointed Jeffrey Benck to be its CEO, effective immediately. He replaces James McCluney, who was named executive chairman of the board. In turn, McCluney displaces ex-chairman Paul Folino, who is to continue to serve as a director.

Top Japanese Stocks To Invest In Right Now: Forest Laboratories Inc (FRX)

Forest Laboratories, Inc. (Forest), incorporated on April 11, 1956, develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include those developed by the Company and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. The Company�� principal products include Lexapro, its selective serotonin reuptake inhibitor (SSRI) for the treatment of major depressive disorder (MDD) in adults and adolescents and generalized anxiety disorder (GAD) in adults; Namenda, its N-methyl-D-Aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension; Savella, its selective serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia and its newest marketed product Teflaro, a broad-spectrum hospital-based injectable cephalosporin antibiotic for the treatment of adults with community-acquired bacterial pneumonia. On April 13, 2011, the Company acquired Clinical Data Inc. (Clinical Data), a specialty pharmaceutical company.

Aclidinium

In June 2011, the Company ahs submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for aclidinium (aclidinium bromide), a long-acting antimuscarinic agent developed as an inhaled therapy for the maintenance treatment of chronic obstructive pulmonary disease (COPD). When given by inhalation, aclidinium leads to bronchodilation by inhibiting airway smooth muscle contraction. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Aclidinium is administered to patients using a multi-dose dry powder inhaler (MDPI). This inhaler was designed with a feedback system which, through a ��olored control window��and an a! udible click, helps confirm that the patient has inhaled correctly. It contains multiple doses of aclidinium, includes a visible dose-level indicator, and also incorporates features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.

Linaclotide

Linaclotide is being investigated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation (CC). Linaclotide is an agonist of the guanylate cyclase type-C receptor found in the intestine and acts by a mechanism. Linaclotide increases fluid secretions leading to increased bowel movement frequency and reduces abdominal pain. Linaclotide is administered orally but acts locally in the intestine with no measurable systemic exposure at therapeutic doses and is intended for once-daily administration.

Viibryd

As a result of its acquisition of Clinical Data, Inc. (Clinical Data) completed in April 2011, the Company obtained worldwide rights to develop and market Viibryd (vilazodone HCl) a selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist developed by Clinical Data for the treatment of adults with major depressive disorder (MDD). Viibryd became available to patients during the June 2011 quarter and was formally launched in the U.S. in late August 2011.

Daliresp

In February 2011, the Company received approval from the United States Food and Drug Administration (FDA) for the marketing of Daliresp (roflumilast). Daliresp is once-daily, orally administered, selective phosphodiesterase 4 (PDE4) enzyme inhibitor, developed by its partner, Nycomed GmbH (Nycomed), as a treatment to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.

Namenda

Namenda (memantine HCl) is an N-methyl-D-Aspartate (NMDA) receptor agonist for the treatmen! t of mode! rate and severe Alzheimer�� disease. In June 2010, Namenda XR was approved by the FDA for the treatment of moderate to severe dementia of the Alzheimer�� type. Namenda XR is a 28 milligrams once-daily extended-release formulation of Namenda. The Company has obtained the exclusive rights to develop and market memantine in the United States by license agreement with Merz Pharma GmbH & Co. KgaA (Merz) of Germany, the originator of the product.

Bystolic

Bystolic is a beta-1 selective beta-blocker with vasodilating properties. Bystolic decreases heart rate and myocardial contractility and suppresses rennin activity. The Company licensed exclusive United States and Canadian rights to Bystolic from Mylan Inc. (Mylan).

Savella

Savella (milnacipran HCl) is the Company�� selective serotonin and norepinephrine inhibitor (SNRI) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function. The Company licensed the United States and Canadian rights to develop and commercialize Savella from Cypress Bioscience, Inc. (Cypress). Its license agreement includes two patents covering the use of Savella for the management of fibromyalgia.

Teflaro

In October 2010, the Company received marketing approval from the FDA for Teflaro (ceftaroline) for the treatment of adults with community-acquired bacterial pneumonia, including cases caused by Streptococcus pneumoniae bacteremia and with acute bacterial skin and skin structure infections, including cases caused by methicillin-resistant Staphylococcus aureus. Teflaro is a spectrum, hospital-based injectable cephalosporin antibiotic with activity against Gram-positive bacteria and common Gram-negative bacteria. Teflaro is a member of the cephalosporin class of antibiotics. The worldwide rights (excluding Japan) to Teflaro are in-licensed on an exclusive basis from Takeda Pharmaceutical Company (Takeda). Teflaro is als! o covered! by two United States patents that relate to the ceftaroline formulation that expire in 2021 and that may provide additional exclusivity.

Avibactam

Avibactam is designed to be co-administered with select antibiotics to enhance their spectrum of activity. The Company received the exclusive rights to administer avibactam with ceftaroline as a combination product in North America. Avibactam is a beta-lactamase inhibitor designed to be co-administered with select antibiotics to enhance their spectrum of activity by overcoming beta-lactamase-related antibacterial resistance.

Lexapro

Lexapro�� is a SSRI for the treatment of MDD in adults and adolescents and GAD in adults. Lexapro�� (escitalopram oxalate) single isomer version of citalopram HBr, for the treatment of MDD in adults and adolescents and GAD in adults.

Cariprazine

Cariprazine is an oral D2/D3 partial agonist. Cariprazine is also undergoing Phase III trials for schizophrenia and acute mania associated with bipolar depression, bipolar depression and as an adjunct treatment for MDD.

Levomilnacipran

Levomilnacipran is a once-daily, selective norepinephrine and serotonin reuptake inhibitor, two neurotransmitters known to play an essential role in regulating mood, and is being developed for the treatment of MDD.

GRT 6005

In December 2010, the Company entered into a license agreement with Grunenthal GmbH for the co-development and commercialization of GRT 6005 and its follow-on compound GRT 6006, small molecule analgesic compounds being developed by Grunenthal for the treatment of moderate to severe chronic pain. GRT 6005 and GRT 6006 are compounds with pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. GRT 6005 has completed initial proof-of-concept studies in nociceptive and neuropathic pain with further Phase II studies planned prior to initiation of Phase III s! tudies.

TTP399

In June 2010, the Company entered into a license agreement with TransTech Pharma, Inc. (TransTech) for the development and commercialization of TTP399, a functionally liver selective glucokinase activator (GKA) discovered and developed by TransTech for the treatment of Type II diabetes. Early Phase I testing suggests that pharmacological enhancement of glucokinase activity may lower blood glucose in diabetic patients.

Azimilide

In April 2011, the Company entered into an agreement with Blue Ash Therapeutics, LLC (Blue Ash) pursuant to which it acquired the worldwide rights to azimilide, a class III antiarrhythmic agent developed by Proctor & Gamble Pharmaceuticals. Based on its mechanism of action and results of clinical trials, azimilide was determined to be suited for use in patients with a history of life-threatening ventricular arrhythmias and who have an implantable cardioverter defibrillator. In 2010, the FDA agreed to one additional Phase III study to support a regulatory submission for azimilide in the U.S.

RGH-618

RGH-618 involves a series of compounds that target metabotropic glutamate receptors and are agonists, which represent potential agents for the treatment of anxiety, depression and other central nervous system (CNS) conditions. In March 2012, the Company initiated a Phase I study in healthy volunteers of RGH-618.

Advisors' Opinion:

• [By Brian Marckx]

  Several large pharma companies have OA drug candidates in various stages of clinical trials including GlaxoSmithKline (GSK), Abbott Laboratories (ABT), and Forest Laboratories (FRX) and would have potentially significant interest in a test such as ILIU's OA test.

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Tuesday’s session are Forest Laboratories Inc.(FRX), Coca-Cola Co.(KO) and Waste Management Inc.(WM)

• [By Johanna Bennett]

  Forest Laboratories (FRX) surged 9.7% to close at $56.32, marking the biggest gain in the S&P 500. The drug maker unveiled plans to trim $500 million in costs, and spend at least $400 million buying back its stock.

• [By Mani]

  Investors of Forest Laboratories, Inc. (NYSE: FRX) is banking on the prospect that Forest, under its newly anointed CEO, will simply become more specialized, shedding salesforce expenses along the way.

Top Japanese Stocks To Invest In Right Now: RealPage Inc.(RP)

RealPage, Inc. provides on demand software solutions for the rental housing industry in North America. It offers property management systems, including OneSite to manage leasing and rents, facilities, purchasing, accounting, budgeting, and living of multi-family, housing and urban development (HUD), tax credit, privatized military housing, and student housing; and Propertyware for accounting, maintenance and work order management, marketing spend management, and portal services, as well as screening, renter?s insurance, and payment solutions. The company also provides on premise property management systems that include RentRoll for small conventional apartment communities; HUD Manager for small HUD, rural housing services, and tax credit subsidized apartment communities; Tenant Pro for small conventional properties; Spectra, an apartment and commercial modular property management system; and i-CAM and Management Plus property management software that automates and streaml ines rental activities. In addition, it offers software-enabled value-added services, such as LeaseStar, a system that manage marketing and leasing operations and enable owners and managers to originate, capture, track, manage, and close leads; YieldStar, a scientific yield management system, which enables owners and managers to optimize rents; LeasingDesk, a risk mitigation system to reduce delinquency, liability, and property damage risk; and Velocity that offers billing and utility management services; OpsTechnology that offers spend management systems that enable owners and managers to control costs; shared cloud services, which are integrated with property management systems and software-enabled valued added services; and RealPage Senior Living, an integrated care management, community management, and marketing management platform. The company sells its software and services directly through its sales force. RealPage, Inc. is headquartered in Carrollton, Texas.

Advisors' Opinion:

• [By Sean Williams]

  For this week's round of "Better Know a Stock," I'm going to take a closer look at RealPage (NASDAQ: RP  ) .

  What RealPage does
  RealPage is a software-as-a-service applications provider to apartment communities and single-family housing developments. The company has a portfolio of cloud-based software products that allow apartment communities to automate leasing, renting, management, and accounting activities. It also provides software capable of helping apartments originate and find new leads, as well as optimize rent yields.

• [By John Udovich]

  Small cap construction software stock Textura Corp (NYSE: TXTR) has been all over the place lately, meaning it might be time to take a look at it along with other small cap or mid cap construction, design or real estate software stocks like RealPage, Inc (NASDAQ: RP) and more well known Autodesk, Inc (NASDAQ: ADSK). After all, enterprise software stocks like these would offer a more indirect way to bet on a housing or construction ��ecovery,���ust like building materials stocks; plus earlier this summer,�a benchmark global study (sponsored by Textura Corp) called Global Construction 2025 predicted that the global construction market will grow by more than 70% to reach $15 trillion by 2025.�

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on RealPage (Nasdaq: RP  ) , whose recent revenue and earnings are plotted below.

• [By Alex Planes]

  What: Shares of RealPage (NASDAQ: RP  ) have been rising since an early morning plunge that shaved more than 11% off their value, and now seem to have stabilized at a loss of about 4% from the previous trading day. Investors seem somewhat displeased that the company's financial results and forward guidance were all so average.

Top Japanese Stocks To Invest In Right Now: CLARCOR Inc. (CLC)

CLARCOR Inc. provides filtration products, filtration systems and services, and consumer and industrial packaging products worldwide. Its Engine/Mobile Filtration segment offers oil, air, fuel, coolant, transmission, and hydraulic fluid filters for engines used in stationary power generation and mobile equipment applications, as well as for marine, construction, industrial, mining, and agricultural equipment. This segment also provides dust collection cartridges for environmental filtration applications The company�s Industrial/Environmental Filtration segment manufactures specialty industrial process liquid filters; filters for pharmaceutical processes and beverages; filtration systems, filters, and coalescers for the oil and natural gas industry; filtration systems for aircraft refueling, anti-pollution, sewage treatment, and water recycling; bilge water separators; sand control filters for oil and gas drilling; and woven wire and metallic products for filtration of pl astics and polymer fibers. This segment also offers antimicrobial treated filters and electronic air cleaners for use in commercial and residential buildings, hospitals, factories, residences, paint spray booths, gas turbine and dust collector systems, medical facilities, motor vehicle and aircraft cabins, clean rooms, and compressors. Its Packaging segment provides metal, plastic, and a combination of metal/plastic containers and closures for packing dry and paste form products, smokeless tobacco products, lip balms, ointments, and consumer healthcare products. This segment also offers shells for dry batteries; canisters for films and candles; spools for insulated and fine wire; and custom decorated flat metal sheets. The company distributes its products through independent distributors, dealers for original equipment manufacturers, retail stores, and internal sales force, as well as directly to end-use customers. CLARCOR Inc. was founded in 1904 and is headquartered in Fra nklin, Tennessee.

Advisors' Opinion:

• [By Tom Lydon]

  Top holdings based on the index include Acadia Healthcare Companies (ACHC), Amsurg Corporation (AMSG), Brookdale Senior Living (BKD), Clarcor (CLC) and Community Health Systems (CYH).

• [By Diane Alter]

  Dividend Stocks That Increased Payout in September

  Accenture plc (NYSE: ACN) announced a 14.8%, or $0.12 per share, increase to its semiannual dividend. The management consulting firm will now pay a semiannual dividend of $0.93. Shares yield 2.53%. Agruim Inc. (NYSE: AGU) boosted its dividend by $1.00 per share to a total dividend of $3.00 on an annualized basis. Shares of the global retailer of agricultural products now sprout a 3.54% yield. Air Industries Group Inc. (NYSE: AIRI) doubled its dividend to $0.125 per share. The maker of airplane and helicopter parts now floats a lofty yield of 6.6%. Alexandria Real Estate Equities Inc. (NYSE: ARE) upped its dividend 4.6% to $0.68 per quarter for a yield of 4.21%. Banner Corp. (Nasdaq: BANR) boosted its quarterly dividend 25% to $0.15 per share. The parent company of Banner and Islander Bank serves the Pacific Northwest region. Brady Corp. (NYSE: BRC) lifted its quarterly dividend 2.6% to $0.78 per share. It was the 28th straight dividend increase from the identification solutions company. Shares yield 2.57%. Campbell Soup Co. (NSE: CPB) raised its quarterly dividend to $0.31 per share, up from $0.29. The company last raised its dividend in November 2010. Shares yield a hearty 3.06%. CLARCOR Inc. (NYSE: CLC) raised its quarterly dividend 26% to $0.17 per share. It's the largest percentage increase from the Tennessee-based diversified marketer of mobile filtration and packaging products in the last 20 years, and it continues the company's consecutive streak of increasing dividends for the last 30 years. Franklin Resources Inc. (NYSE: BEN) boosted its quarterly dividend 2.6% to $0.10 per share. Frisch's Restaurants Inc. (NYSE: FRS) increased its quarterly dividend 12.5% to $0.18. Shares yield 3.10% The Goodyear Tire & Rubber Company (NYSE: GT), in a move that suggests good times are ahead, reinstated its dividend at $0.05 per share. Good
• [By Marc Bastow]

  Filtration and packaging product provider Clarcor (CLC) announced a 26% dividend increase to 17 cents per share, payable Oct. 18 to shareholders of record as of Oct. 11.
  CLC Dividend Yield: 1.22%

Top Biotech Companies To Buy Right Now

Last week, investors freaked out when biotech giant Gilead (GILD) announced its 2014 outlook and didn’t include Sovaldi in its calculations.

Getty Images

Argus analyst David Toung explains why Sovaldi would make the Gilead’s numbers look even better:

In issuing guidance for 2014, Gilead notably excluded any sales from Sovaldi, even though it has been approved in the U.S., Canada and Europe. It expects 2014 sales from core products, excluding Sovaldi, of $11.3-$11.5 billion, an increase of 6%- 8% from 2013. It also projects a product gross margin of 75%-77%. It did not provide specific EPS guidance. Management expects to increase sales and marketing spending to support the launch of Idelalisib, its first oncology drug. It also expects to increase R&D spending to develop its product pipeline. As for Sovaldi, Gilead noted that every $1 billion of incremental Sovaldi sales would increase the gross margin by 75- 100 basis points and reduce the tax rate by 75-100 basis point

Hot Up And Coming Stocks For 2015: KaloBios Pharmaceuticals Inc (KBIO)

KaloBios Pharmaceuticals, Inc., is a United States-based company, which develops protein therapeutics. The Company develops and engineers antibodies and protein therapeutics. Its monoclonal antibodies (mAbs) technology that is being used for reengineering antibodies with products being developed in the areas of infectious disease, autoimmunity, and oncology. Its suite of technologies can also be used for discovery and engineering of other proteins, industrial enzymes and small molecule drugs. It conducts three clinical development programs in leukemia, infectious diseases, and autoimmune diseases. Advisors' Opinion:

• [By Monica Gerson]

  KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO) shares fell 64.48% to $0.65 in pre-market trading after the company reported top-line data from phase 2 study of KB001-A.

Top Biotech Companies To Buy Right Now: Alcobra Ltd (ADHD)

Alcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse. MG01CI product has completed phase two studies. Advisors' Opinion:

• [By MONEYMORNING.COM]

  For example, a phase 3 clinical trial on metadoxine extended release as a treatment for adult attention deficit hyperactivity disorder (ADHD) will be finishing up at the end of this year. Positive data could give the stock a huge boost.

• [By Roberto Pedone]

  A biopharmaceutical stock that's starting to trend within range of triggering a big breakout trade is Alcobra (ADHD), which is engaged in the development and commercialization of its proprietary drug, MG01CI, to treat attention deficit hyperactivity disorder. This stock has been on fire so far in 2013, with shares up huge by 126%.

  If you take a look at the chart for Alcobra, you'll notice that this stock has been trending sideways and consolidating over the last month and change, with shares moving between $14.78 on the downside and $18.75 on the upside. Shares of ADHD have now started to uptrend a bit over the last few weeks, with shares moving higher from its low of $15.05 to its recent high of $18.45 share. That move has started to push shares of ADHD within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.

  Traders should now look for long-biased trades in ADHD if it manages to break out above its 50-day moving average of $17.79 a share, and then once it takes out some more key overhead resistance levels at $18.45 to $18.75 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 74,869 shares. If that breakout triggers soon, then ADHD will set up to re-test or possibly take out its next major overhead resistance levels at $22 to $24 a share. Any high-volume move above those levels will then give ADHD a chance to re-test or possibly take out its all-time high at $26.96 a share.

  Traders can look to buy ADHD off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support levels at $16.17 to $15.05 a share, or around $14.78 a share. One could also buy ADHD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Biotech Companies To Buy Right Now: Durata Therapeutics Inc (DRTX)

Durata Therapeutics, Inc., incorporated on November 4, 2009, is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections (abSSSI). Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing. In addition to abSSSI, the Company focuses on the development of dalbavancin for additional indications, including osteomyelitis, diabetic foot infection and pneumonia.

As of December 31, 2011, Dalbavancin had already completed three Phase III clinical trials, in which more than 1,000 patients in total received dalbavancin. Dalbavancin achieved its primary efficacy endpoint of non-inferiority in each of these three completed Phase III clinical trials when compared to linezolid, cefazolin or vancomycin, three of the standard-of-care agents for uncomplicated skin and skin structure infections (uSSSI), and complicated skin and skin structure infections (cSSSI). Its two ongoing Phase III clinical trials are designed to compare dalbavancin to vancomycin, with an option to switch to oral linezolid, under the new FDA draft guidance.

The Company competes with Pfizer, Cubist Pharmaceuticals, Inc., Theravance, Inc., Forest Laboratories, Inc., Sanofi-Aventis Ltd., The Medicines Company, Trius Therapeutics, Inc., Cempra, Inc., Rib-X Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc., Nabriva Therapeutics AG, Tetraphase Pharmaceuticals, Inc. and Furiex Pharmaceuticals, Inc.

Advisors' Opinion:

• [By Lisa Levin]

  Durata Therapeutics (NASDAQ: DRTX) shares climbed 5.30% to $14.18. The volume of Durata Therapeutics shares traded was 861% higher than normal. The FDA Advisory Committee unanimously recommended the approval of Durata's Dalvance.

• [By Bob's Stocks]

  Durata Therapeutics (DRTX) is developing Dalbavancin, a once a week, intravenous antibiotic product candidate, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. The company is expected to file a NDA (New Drug Application) at any moment and MAA (Marketing Authorization Application) at the end of 2013.

Top Biotech Companies To Buy Right Now: Brainstorm Cell Therapuetics Inc (BCLI)

Brainstorm Cell Therapeutics Inc. (Brainstorm), incorporated on November 15, 2006, is a biotechnology company developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson�� disease (PD). These diseases have limited treatment options and as such represent unmet medical needs. The Company�� NurOwn technology is based on a differentiation protocol, which induces differentiation of the bone marrow-derived mesenchymal stem cells into neuron-supporting cells, MSC-NTF cells, capable of releasing several neurotrophic factors, including Glial-derived neurotrophic factor (GDNF) and Brain-derived neurotrophic factor (BDNF), Vascular endothelial growth factor (VEGF) and Hepatocyte growth factor (HGF), which are critical for the growth, survival and differentiation of developing neurons.

The Company�� approach to treatment of neurodegenerative diseases with autologous adult stem cells includes a multi-step process beginning with harvesting of undifferentiated stem cells from the patient's own bone marrow, and concluding with transplantation of differentiated, neurotrophic factor-secreting mesenchymal stem cells (MSC-NTF) into the same patient-intrathecally and/or intramuscularly. Intrathecal (injection into the cerebrospinal fluid) transplantation consists of injection with a standard lumbar puncture; there is no need for a laminectomy -an invasive, orthopedic spine operation to remove a portion of the vertebral bone, as required by other technologies. Intramuscular (injection directly into muscle) transplantation is performed via a standard injection procedure as well. Its production process for induction of differentiation of human bone marrow derived mesenchymal stem cells into differentiated cells that produce NTF (MSC-NTF) for clinical use is conducted in full compliance with current Good Manufacturing Practice (cGMP).

Advisors' Opinion:

• [By John Udovich]

  Small cap ALS and stem cell stock�Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) surged 22.68%�ahead if its Monday ice bucket challenge when they will release the final results from�a phase 2a clinical trial���meaning its worth taking a closer look at the stock along with the performance of stem cell stocks or ALS stocks like Cytokinetics, Inc (NASDAQ: CYTK), Neuralstem, Inc (NYSEMKT: CUR) and NeoStem Inc (NASDAQ: NBS). However, Brainstorm Cell Therapeutics does have a history of being the subject of paid promotions and/or investor relations activities when it was trading on the OTC.

Top 5 Gas Utility Stocks For 2014

Hasbro Inc. (HAS) reported its first quarter earnings before the opening bell on Monday, posting higher revenue than last year’s first quarter.

Hasbro’s Earnings in Brief

HAS reported first quarter revenues of $679.45 million, which were up 2% from last year’s Q1 revenues of $663.69 million. Net earnings for the quarter came in at $31.51 million, up from last year’s first quarter loss of $6.67 million. The company�� adjusted operating profit was $18.6 million, or 14 cents per share, up from last year’s Q1 figure of $13.5 million, or 10 cents per share. Hasbro’s results beat analysts’ EPS estimates of 10 cents, but revenues came in slightly below view of $686.91 million.

CEO Commentary

Best European Stocks To Buy Right Now: PetroLogistics LP (PDH)

PetroLogistics LP owns and operates propane dehydrogenation (PDH) facility. The Company is located in the vicinity of the Houston Ship Channel. As of April 23, 2012, the Company had an annual production capacity of approximately 1.45 billion pounds of propylene. Its PDH facility uses a CATOFIN dehydrogenation technology pursuant to a fully-paid license from CB&I Lummus. It derives its sales from three different sources: propylene sales, hydrogen sales, and mixed stream of butane and butylenes (C4 mix stream) and heavier hydrocarbons (C5+ stream) sales.

Contracted Propylene Sales

The Company has propylene sales contracts with The Dow Chemical Company (Dow), Total Petrochemicals USA, Inc. (Total), and INEOS Olefins and Polymers USA (INEOS), each of which use the propylene it supplies in the acrylic acid, polypropylene and acrylonitrile plants. Effective January 1, 2012, it added BASF Corporation (BASF) and LyondellBasell Industries N.V. (LyondellBasell) as additional contracted customers. It delivers propylene to these customers through its integrated pipeline system, which connects its facility to the Dow and Total plants and the LyondellBasell system, and through interconnected third-party pipelines, which connect its facility to INEOS and BASF and to other potential propylene customers.

Spot-Market Propylene Sales

Through the Company�� integrated pipeline system, the Company accesses other consumers of propylene, which it is able to supply on a spot basis with its excess production capacity. It manages its contract and spot portfolio.

Hydrogen Gas Sales

As part of the PDH process, the Company produces commercial quantities of hydrogen. Hydrogen is consumed in refinery processes, including fuel desulphurization.

C4 Mix/C5+ Streams Sales

The Company produces commercial quantities of C4 mix/C5+ streams. It sells the C4 mix stream to specialty chemical consumers or refiners and these customers tran! sport the purchased volumes from its facility by truck. The C5+ stream, which is heavy in aromatics, is transported by its pipeline to a Kinder Morgan terminal, and then sold to Texas Aromatics for use in the chemical or gasoline markets.

The Company competes with Enterprise, Chevron Phillips, ExxonMobil Chemical, Shell Chemical, Flint Hills and the Williams Companies.

Advisors' Opinion:

• [By Seth Jayson]

  PetroLogistics (NYSE: PDH  ) reported earnings on July 24. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), PetroLogistics met expectations on revenues and beat expectations on earnings per share.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on PetroLogistics (NYSE: PDH  ) , whose recent revenue and earnings are plotted below.

• [By Travis Hoium]

  What: Shares of propane company PetroLogistics (NYSE: PDH  ) fell as much as 10% today after reporting earnings.

  So what: Sales dropped 18% from a year ago to $159.4 million but the company swung to a net income of $41.4 million. On an adjusted basis net income fell from $64.4 million a year ago to $37.8 million in the second quarter. �

Top 5 Gas Utility Stocks For 2014: USA Technologies Inc.(USAT)

USA Technologies, Inc. supplies cashless, remote management, reporting, and energy management solutions for the unattended point of sale market primarily in the United States. The company offers networked devices and associated services that enable the owners and operators of stand-alone distributed assets, such as vending machines, kiosks, personal computers, photocopiers, and laundry equipment the ability to remotely monitor, control, and report on the results of these distributed assets, as well as the ability to offer their customers cashless payment options. Its products include Intelligent Vending, an ePort connect solution for the vending industry; Kiosk, an ePort solution that offers an electronic payment option and Web-based remote monitoring and management for various kiosk types; eSuds, a solution for the commercial laundry industry; Business Express, which provides self-service business center solutions to the hotel and motel industry; and ePort Transact soluti on for the self-service business center devices, such as printers and copy machines. The company also manufactures and sells energy conservation products comprising VendingMiser, CoolerMiser, VM2IQ and CM2IQ, SnackMiser, and PlugMiser for various existing equipment, including refrigerated vending machines and glass front coolers. USA Technologies, Inc. was founded in 1992 and is based in Malvern, Pennsylvania.

Advisors' Opinion:

• [By Monica Gerson]

  USA Technologies (NASDAQ: USAT) is projected to report its Q3 earnings at $0.00 per share on revenue of $10.63 million.

  P&F Industries (NASDAQ: PFIN) is expected to report its quarterly results.

• [By Monica Gerson]

  USA Technologies (NASDAQ: USAT) is estimated to report its Q4 earnings at $0.02 per share on revenue of $9.89 million.

  Vail Resorts (NYSE: MTN) is projected to post a Q4 loss at $1.71 per share on revenue of $117.82 million.

Top 5 Gas Utility Stocks For 2014: StemCells Inc (STEM)

StemCells, Inc. (StemCells), incorporated in August 1988, is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies, and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. The Company�� primary research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The Company has two therapeutic product development programs, including its CNS Program, which is developing applications for HuCNS-SC cells, its human neural stem cell product candidate, and its Liver Program, which is characterizing the Company�� human liver cells as a therapeutic product.

CNS Program

The Company in its CNS Program, is in clinical development with its HuCNS-SC cells for a range of disorders of the central nervous system. The CNS includes the brain, spinal cord and eye. In February 2012, the Company had completed a Phase I clinical trial in Pelizeaus-Merzbacher Disease (PMD), a fatal myelination disorder in the brain.

The Company�� CNS Program is focused on developing clinical applications, in which transplanting HuCNS-SC cells protect or restore organ function of the patient before such function is irreversibly damaged or lost due to disease progression. The Company�� initial target indications are PMD, and more generally, diseases in which deficient myelination plays a central role, such as cerebral palsy or multiple sclerosis; spinal cord injury, disorders in which retinal degeneration plays a central role, such as age-related macular degeneration or retinitis pigmentosa. The Company�� product candidate, HuCNS-SC cells, is a purified and expanded composition of normal human neural stem cells. Its HuCNS-SC cells can be directly transp! lanted.

Liver Program

Liver stem or progenitor cells offer an alternative treatment for liver diseases. A liver cellular therapy or cell-based therapeutic provide or support liver function in patients with liver disease. The Company held a portfolio of issued and allowed patents in the liver field, which cover the isolation and use of both hLEC cells and the isolated subset, as well as the composition of the cells themselves.

The Company�� range of cell culture products, which are sold under the SC Proven brand, includes iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff N2, and NDiff N2B27. Its iSTEM is a serum-free, feeder-free medium that maintains mouse embryonic stem cells in their pluripotent ground state by using selective small molecule inhibitors to block the pathways, which induce differentiation. RHB-A is a defined, serum-free culture medium for the selective culture of human and mouse neural stem cells and their maintenance and expansion as adherent cell populations. RHB-Basal is a defined, serum-free basal medium. When supplemented with specific growth factors, this media is formulated for the propagation and differentiation of adherent neural stem cells. RHB-Basal can also be tailored to specific-cell type requirements by the addition of customer preferred supplements.

The Company�� NDiff N2 is a defined serum-free scell culture supplement for the derivation, maintenance, expansion and/or differentiation of human and mouse embryonic stem (ES) cells and tissue-derived neural stem cells supplement. Its NDiff N2-AF is a serum-free and animal component-free version of NDiff N2. Its NDiff N2B27 is a defined, serum-free medium for the differentiation of mouse embryonic stem cells to neural cell types. NDiff N27-AF is a serum-free and animal component-free version of NDiff N27. Its GS1-R is a serum-free media formulation shown to enable the derivation and long-term maintenance of true, germline competent rat embryonic stem cells without the add! ition of ! cytokines or growth factors. Its GS2-M is a defined, serum- and feeder-free medium for the derivation and long-term maintenance of true, germline competent mouse iPS cells.

The Company also markets a number of antibody reagents for use in cell detection, isolation and characterization. These reagents are also under the SC Proven brand and it includes STEM24, STEM101, STEM121 and STEM123. Its STEM24 is a human antibody that recognizes human CD24, also known as heat stable antigen (HSA), a glycoprotein expressed on the surface of many human cell types, including immature human hematopoietic cells, peripheral blood lymphocytes, erythrocytes and many human carcinomas. Its CD24 is also a marker of human neural differentiation. Its STEM101 is a human-specific mouse antibody that recognizes the Ku80 protein found in human nuclei. Its STEM121 is a human-specific mouse antibody that recognizes a cytoplasmic protein of human cells. Its STEM123 is a human-specific mouse antibody that recognizes human glial fibrillary acidic protein (GFAP).

The Company�� Other products marketed under SC Proven include total cell genomic DNA (gDNA), RNA and protein lysate reagents purified from homogenous stem cell populations for intra-comparative studies, such as Epigenetic fingerprinting, Southern, Western and Northern blots, PCR, RT-PCR and microarrays. This range of purified stem cell line lysates includes mouse embryonic stem (ES) cells propagated in SC Proven 2i inhibitor-based GS2-M media and mouse ES cell-derived and fetal tissue-derived neural stem (NS) cells propagated in SC Proven RHB-A media.

Advisors' Opinion:

• [By John Udovich]

  The results of a recent Pew Center Poll regarding attitudes towards abortion and various forms of stem cell research could be a good sign for the stem cell industry along with small cap stem cell stocks like StemCells Inc (NASDAQ: STEM), NeoStem Inc (NASDAQ: NBS), Neuralstem, Inc (NYSEMKT: CUR),�International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX). Basically, Americans think that having an abortion is a moral issue with 49% of American adults believing abortion is morally wrong, 23%�view it not as a moral issue and and 15% view it as morally acceptable. However and when Americans were asked about issues surrounding�human embryos, such as stem cell research or in vitro fertilization, as a matter of morality, their views were different.

• [By Garrett Cook]

  Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

• [By James E. Brumley]

  When an investor thinks of spinal-related stem cell stocks, usually a name like Neuralstem, Inc (NYSEMKT: CUR) or StemCells Inc (NASDAQ: STEM) comes to mind. And well they should. STEM has logged some amazing breakthroughs in the field of spinal cord repair, while CUR has done the same. Not all back problems are spinal cord related though. In fact, most back problems - and therefore the most opportunity - are bone and disc related problems. That's where a young gun like BioRestorative Therapies (OTCBB: BRTX) can step in and make stem cell waves. BRTX has developed an approach to rejuvenate and revive failing spinal discs, potentially ending pain for millions of back-pain sufferers, and circumventing expensive spinal surgeries that are in increasing burden on insurance companies.

Top 5 Gas Utility Stocks For 2014: ANSYS Inc (ANSS)

ANSYS, Inc. (ANSYS) develops and globally markets engineering simulation software and services used by engineers, designers, researchers and students across a range of industries and academia, including aerospace, automotive, manufacturing, electronics, biomedical, energy and defense. The Company distributes its ANSYS suite of simulation technologies through a global network of independent resellers and distributors (collectively, channel partners) and direct sales offices in global locations. The Company�� product portfolio consists of ANSYS Workbench, multiphysics product, structural mechanics, fluid dynamics, explicit dynamics, electromagnetic, system simulation, simulation process and data management, academic, high-performance computing (HPC), geometry interfaces, meshing and Apache design low-power electronic solutions. On August 1, 2011, the Company acquired Apache Design, Inc.

ANSYS Workbench

ANSYS Workbench is the framework upon which the Company�� suite of advanced engineering simulation technologies is built. The ANSYS Workbench platform delivers productivity, enabling Simulation Driven Product Development.

Multiphysics

The Company�� multiphysics product suite allows engineers and designers to create virtual prototypes of their designs operating under multiphysics conditions. ANSYS multiphysics software enables engineers and scientists to simulate the interactions between structural mechanics, heat transfer, fluid flow and electromagnetics all within a single, engineering simulation environment.

Structural Mechanics

The Company�� structural mechanics product suite offers simulation tools for product design. These tools have capabilities that cover a range of analysis types, elements, contacts, materials, equation solvers and coupled physics capabilities all focused towards understanding and solving complex design problems.

Fluid Dynamics

The Company�� fluid dynamics product suit! e offers modeling of fluid flow and other related physical phenomena. Fluid flow analysis capabilities provide all the tools needed to design new fluids equipment and to troubleshoot already existing installations. The fluid dynamics product suite contains general-purpose computational fluid dynamics software and specialized products to address specific industry applications.

Explicit Dynamics

The Company�� explicit dynamics product suite simulates events involving short-duration, large-strain, large-deformation, fracture, complete material failure or structural problems with complex interactions. This product suite is used for simulating physical events that occur in a short period of time and may result in material damage or failure.

Electromagnetics

The Company�� electromagnetics product suite provides field simulation software for designing high-performance electronic and electromechanical products. The software streamlines the design process and predicts performance - all prior to building a prototype - of mobile communication and Internet-access devices, broadband networking components and systems, integrated circuits (IC) and printed circuit boards (PCB), as well as electromechanical systems such as automotive components and power electronics equipment.

System Simulation

The Company delivers the ability to perform complete simulation studies as a system for some of the product designs. This is accomplished through a complete set of physics solutions that are integrated into a multiphysics capabilities set. A collaborative simulation environment provides modeling scalability for evaluating entire systems, including three dimensional (3-D) high-fidelity models, multibody dynamics, circuit reduced-order models, and any combination of these.

Simulation Process and Data Management

ANSYS Engineering Knowledge Manager (ANSYS EKM) is a solution for simulation-based process and data management. ANSY! S EKM pro! vides solutions to all levels of a company, enabling an organization to address the issues associated with simulation data, including backup and archival, traceability and audit trail, process automation and intellectual property protection.

Academic

The Company�� academic product suite provides a portfolio of academic products based on several usage tiers: associate, research and teaching. Each tier includes various noncommercial products that bundle a range of physics and advanced coupled field solver capabilities. The academic product suite provides entry-level tools intended for class demonstrations and hands-on instruction. It provides flexible terms of use and more complex analysis suitable for doctoral and post-doctoral research projects. The Company also provides a product suitable for student use at home.

High-Performance Computing

The Company�� HPC product suite enables insight into product performance. The HPC product suite delivers cross-physics parallel processing capabilities for the full spectrum of the Company�� simulation software by supporting structural, fluids, thermal and electromagnetic simulations in a single HPC solution.

Geometry Interfaces

The Company offers geometry handling solutions for engineering simulation in an integrated environment with direct interfaces to all CAD systems, support of additional readers and translators. It also offers an integrated geometry modeler focused on analysis.

Meshing

Creating a mesh that transforms a physical model into a mathematical model is a critical and foundational step in almost every engineering simulation study. The Company�� meshing technology provides a means to balance these requirements, obtaining the right mesh for each simulation in the most automated way possible.

Apache Design Low-Power Electronic Solutions

The Company�� suite of Apache software delivers power analysis and optimization pl! atforms a! long with integrated methodologies that provide capabilities for managing the power budget, power delivery integrity, and power-induced noise in an electronic design, from initial prototyping to system sign-off. These solutions deliver correlation to silicon measurement, and the capacity to handle an entire electronic system, including IC, package, and PCB.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Ansys (Nasdaq: ANSS  ) , whose recent revenue and earnings are plotted below.

• [By Jonas Elmerraji]

  We're seeing the exact same setup in shares of simulation software maker ANSYS (ANSS). Like CSC, ANSYS is sandwiched between a horizontal price ceiling above shares around $90 a share and a similar horizontal floor at $83.50 a share. From here, the trading signal comes on a breakout outside of the channel.

  Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Rectangles, triangles, and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable – instead, it all comes down to supply and demand for shares.

  That $90 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant – the move means buyers are finally strong enough to absorb all of the excess supply above that price level. Don't be early on this trade.

• [By GURUFOCUS]

  ANSYS, Inc. (ANSS), the market leader in simulation-driven product development software, declined after reporting quarterly results that were negatively impacted by slower end market demand. Despite the near-term headwind, we believe that ANSYS remains the dominant global provider of simulation software and that the company stands to benefit from the ongoing adoption of its simulation tools. We also believe that ANSYS will increasingly use its cash to repurchase its shares, which we believe will generate additional shareholder value.

The Dodgy Dogs of the Dow and Other Backward-Looking Gimmicks

Legend has it a guy with buckets of money once said: "The time to buy is when there is blood in the streets." [i] Words of wisdom, to a point! But some are taking them a bit too literally right now, suggesting folks plow into certain sectors or stocks simply because they've been hammered. Here is some friendly advice: Trading on past price movement alone isn't a winning strategy.

Consider Energy stocks, the current object of blood-in-the-streets lust. The MSCI World Energy Index is down -11.2% in 2014 (the full World Index, by comparison, is up 5.6%)[ii], and a growing chorus is urging investors to pile in—because what goes down must surely rebound, and who doesn't love a bargain!

[Related -Another Solid Year With Expectations of Further Gains but Higher Volatility in 2015]

[Related -Technical Weakness in the Technology Sector]

Trouble is, this ignores some key factors, like sentiment and the why behind Energy's slide. When markets punish sectors or stocks for the wrong or short-sighted reasons, you can find good bargains. Sometimes things just get hammered regardless of their longer-term potential. If you can identify and scoop them up, great—you'll be ahead of the fearful masses and ready to enjoy a nice ride higher once they catch on and bid prices back up.

This isn't what's happening in Energy right now. Energy stocks are down for a reason: Their revenues are price-sensitive, not volume-sensitive, making low crude oil prices a massive headwind. Everyone's paying attention to Energy now, with WTI crude sliding 45% year to date through 12/30[iii] and Energy stock prices down. But Energy stocks have underperformed since 2011, as the shale boom kept prices in check, driving Energy earnings down in 7 of the last 11 quarters. The recent steep slide in prices only illuminates a longer-running negative, and with supply still high, prices aren't likely to skyrocket and restore rip-roaring earnings growth any time soon. Energy stocks might not keep falling, but they hardly look poised for the run of the century.

Plus, as another guy[iv] once said, the time to be greedy is when others are fearful. We are hard-pressed to see much fear in Energy right now. On the contrary, it is darned popular! Not just with the bargain-pitching pundits. Energy sector ETF inflows hit record highs in December! Some would say this is the smart money seizing a contrarian opportunity, but that's a misnomer. Contrarianism just means thinking independently and not getting caught up in crowd mentality. The rush into Energy smacks of herding and later-stage bull market greed. The reasoning has nothing to do with fundamentals and everything to do with mean-reversion and Energy stocks' outperformance during the last decade. Few are looking forward, which means few see the headwinds facing Energy stocks for the foreseeable future. That makes them too popular. Not that we'd suggest avoiding the sector entirely—diversify! But a massive overweight seems unlikely to add much value looking forward.

Similar logic applies to another dog-chasing strategy gaining notice (as it does at the end of every year): The "Dogs of the Dow."[v] This tactic, beloved in the retail brokerage world for its commission-generating prowess, involves buying the 10 DJIA stocks with the highest dividend at year-end (yay), assuming their prices are probably near troughs and will bounce the next year (yay). Now, we won't bore you by rehashing our many, many, many, many issues with the Dow itself—just know it's a broken, limited index. But that isn't the only reason the Dogs of the Dow is a broken, limited strategy. For one, it ignores the fact some or all the 10 could have fundamental problems or are in sectors with big headwinds over the foreseeable future. Bounces aren't guaranteed—you could end up concentrated in companies with limited potential, bypassing much better opportunities among the world's other 8,594 publicly traded firms.[vi] That's probably why audits of the strategy show it's largely all bark.

Plus, it's too dividend-focused. Dow-dogs logic says DJIA stocks pay high dividends per share, and if you buy when prices are down, you get a higher yield and that is wonderful because yield rules! Except, yield doesn't rule. Dividends can be cut or eliminated at any time and, contrary to prevailing myth, DJIA stocks have eliminated dividends. Plus, if you're using your portfolio to generate cash flow, your total return, not yield alone, will determine how much cash you can kick off without raising the risk of depleting your portfolio prematurely. Price returns matter too, and high-dividend stocks don't always perform well. Investing for total return gives you much more flexibility than you'd otherwise have—selling shares now and then to raise cash for your daily needs isn't on the naughty list. It's ok.

In short: "Dogs of the Dow," like Energy bounce seeking, is a gimmick. The associated spin might sound tempting to mimic! But we suggest approaching it like a cynic. Cut through spin, weigh facts, and find the overlooked, real opportunities.

Stock Market Outlook

Like what you read? Interested in market analysis for your portfolio? Why not download our in-depth analysis of current investing conditions and our forecast for the period ahead. Our latest report looks at key stock market drivers including market, political, and economic factors. Click Here for More!

 

[i] As the story goes, Benjamin Disraeli attributed it to Nathan Rothschild, but historical research has proven this false. Though Rothschild was quite good at buying when there was blood in the streets, both figuratively (after markets tanked) and literally (at the bloody depths of the Napoleonic wars). 

Top 10 Managed Healthcare Companies To Buy For 2015

Top 10 Managed Healthcare Companies To Buy For 2015: Xerium Technologies Inc.(XRM)

Xerium Technologies, Inc. manufactures and supplies consumable products used in the production of paper clothing and roll covers primarily in North America, Europe, South America, and the Asia-Pacific. It operates in two segments, Clothing and Roll Covers. The Clothing segment provides various types of industrial textiles used on paper-making machines and other industrial applications. This segment offers forming fabrics, press felts, and dryer fabrics; and fabrics used in other industrial applications, such as pulp, steel, plastics, leather, and textiles manufacturing. The Roll Covers segment manufactures, refurbishes, and replaces roll covers for working rolls, including vacuum rolls and press rolls; calendar rolls; and coater rolls that are used on paper-making machines. This segment also refurbishes previously installed roll covers; provides mechanical maintenance and repair services for the internal mechanisms of rolls used on paper-making machines; and manufactures a nd repairs spreader rolls. The company markets its products through its direct sales force under Huyck Wangner, Weavexx, Stowe Woodward, Mount Hope, Robec, and Xibe brand names. Xerium Technologies, Inc. was founded in 1999 and is headquartered in Raleigh, North Carolina.

Advisors' Opinion:

• [By Roberto Pedone]

  One cyclical consumer goods player that's starting to trend within range of triggering a near-term breakout trade is Xerium Technologies (XRM), a manufacturer and supplier of two types of consumable products, clothing and roll covers, used mainly in the production of paper. This stock has been on fire so far in 2013, with shares up sharply by 313%.

  If you take a look at the chart for Xerium Technologies, you'll notice that this stock has been uptrending strong for the last two months and change, with shares moving higher from its low of $9.94 to its recent high of $12.97 a share. During tha! t uptrend, shares of XRM have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of XRM within range of triggering a near-term breakout trade.

  Traders should now look for long-biased trades in XRM if it manages to break out above some near-term overhead resistance at $12.97 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 100,685 shares. If that breakout triggers soon, then XRM will set up to re-test or possibly take out its 52-week high at $14.04 a share. Any high-volume move above that level will then give XRM a chance to tag its next major overhead resistance levels at $18 to $20 a share.

  Traders can look to buy XRM off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12.28, or near its 50-day at $11.35 a share. One can also buy XRM off strength once it takes out $12.97 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-10-managed-healthcare-companies-to-buy-for-2015.html

Top 5 Transportation Stocks For 2015

Top 5 Transportation Stocks For 2015: Boardwalk Pipeline Partners LP (BWP)

Boardwalk Pipeline Partners, LP is a limited partnership company. The Company owns and operates three interstate natural gas pipeline systems including integrated storage facilities. Its business is conducted by its primary subsidiary, Boardwalk Pipelines, LP (Boardwalk Pipelines) and its subsidiaries, Gulf Crossing Pipeline Company LLC (Gulf Crossing), Gulf South Pipeline Company, LP (Gulf South) and Texas Gas Transmission, LLC (Texas Gas) (together, the operating subsidiaries), which consist of integrated natural gas pipeline and storage systems. During the year ended December 31, 2011, it formed Boardwalk Midstream, LP (Midstream), and its operating subsidiary, Boardwalk Field Services, LLC (Field Services), which is engaged in the natural gas gathering and processing business. In December 2011, Boardwalk HP Storage Company, LLC (HP Storage), a joint venture between Boardwalk Pipelines and Boardwalk Pipelines Holding Corp. (BPHC) acquired Petal Gas Storage, L.L.C. (Peta l), Hattiesburg Gas Storage Company (Hattiesburg). In December 2011, it acquired a 20% equity interest in HP Storage.

The Company's pipeline systems originate in the Gulf Coast region, Oklahoma and Arkansas and extend north and east to the midwestern states of Tennessee, Kentucky, Illinois, Indiana and Ohio. It serves a mix of customers, including producers, local distribution companies (LDCs), marketers, electric power generators, direct industrial users and interstate and intrastate pipelines. The Company provides a portion of its pipeline transportation and storage services, through firm contracts, under which the Company's customers pay monthly capacity reservation charges. Other charges are based on actual utilization of the capacity under firm contracts and contracts for interruptible services. During 2011, approximately 82% of its revenues w! ere derived from capacity reservation charges under firm contracts; approximately 14% of its revenues were deriv ed from charges-based on actual utilization under firm contr! acts, and approximately 4% of its revenues were derived from interruptible transportation, interruptible storage, parking and lending (PAL) and other services. Its expansion projects include South Texas Eagle Ford Expansionand Marcellus Gathering System and HP Storage.

Pipeline and Storage Systems

The Company's operating subsidiaries own and operate approximately 14,200 miles of pipelines, directly serving customers in twelve states and indirectly serving customers throughout the northeastern and southeastern United States through numerous interconnections with unaffiliated pipelines. In 2011, its pipeline systems transported approximately 2.7 trillion cubic feet of gas. Average daily throughput on its pipeline systems during 2011 was approximately 7.3 billion cubic feet. Its natural gas storage facilities are comprised of eleven underground storage fields located in four states with aggregate working gas capacity of approximately 167.0 billion cu bic feet. the Company operates the assets of HP Storage on behalf of the joint venture.

The principal sources of supply for our pipeline systems are regional supply hubs and market centers located in the Gulf Coast region, including offshore Louisiana, the Perryville, Louisiana area, the Henry Hub in Louisiana and the Carthage, Texas area. Its pipelines in the Carthage, Texas area provide access to natural gas supplies from the Bossier Sands, Barnett Shale, Haynesville Shale and other gas producing regions in eastern Texas and northern Louisiana. The Henry Hub serves as the designated delivery point for natural gas futures contracts traded on the New York Mercantile Exchange. Its pipeline systems also have access to unconventional mid-continent supplies, such as the Woodford Shale in southeastern Oklahoma and the Fayetteville Shale in Arkansas. ! The Compa! ny also accesses the Eagle Ford Shale in southern Texas; wellhead supplies in northern and southern Louisiana and Mississippi; and Canadian natural gas through an unaffil! iated pip! eline interconnect at Whitesville, Kentucky.

Gulf Crossing

The Company's Gulf Crossing pipeline system originates near Sherman, Texas, and proceeds to the Perryville, Louisiana area. The market areas are in the Midwest, Northeast, Southeast and Florida through interconnections with Gulf South, Texas Gas and unaffiliated pipelines.

Gulf South

The Company's Gulf South pipeline system is located along the Gulf Coast in the states of Texas, Louisiana, Mississippi, Alabama and Florida. The on-system markets directly served by the Gulf South system are generally located in eastern Texas, Louisiana, southern Mississippi, southern Alabama, and the Florida Panhandle. These markets include LDCs and municipalities located across the system, including New Orleans, Louisiana; Jackson, Mississippi; Mobile, Alabama; and Pensacola, Florida, and other end-users located across the system, including the Baton Rouge to New Orleans industrial corridor and Lake Charles, Louisiana. Gulf South also has indirect access to off-system markets through numerous interconnections with unaffiliated interstate and intrastate pipelines and storage facilities. These pipeline interconnections provide access to markets throughout the northeastern and southeastern United States.

Gulf South has two natural gas storage facilities. The gas storage facility located in Bistineau, Louisiana, has approximately 78 billion cubic feet of working gas storage capacity from which Gulf South offers firm and interruptible storage service, including no-notice service. Gulf South's Jackson, Mississippi, gas storage facility has approximately five billion cubic feet of working gas storage capacity, which is used for operational purposes and is not offered for sale to the market.

Tex! as Gas

The Company's Texas Gas pipeline system originates in Louisiana, East Texas and Arkansas and runs north and east through Louisiana, Arkansas, Mississippi, Tennessee, K! entucky, ! Indiana, and into Ohio, with smaller diameter lines extending into Illinois. Texas Gas directly serves LDCs, municipalities and power generators in its market area, which encompasses eight states in the South and Midwest and includes the Memphis, Tennessee; Louisville, Kentucky; Cincinnati and Dayton, Ohio, and Evansville and Indianapolis, Indiana metropolitan areas. Texas Gas also has indirect market access to the Northeast through interconnections with unaffiliated pipelines. Texas Gas owns nine natural gas storage fields, of which it owns the majority of the working and base gas. Texas Gas uses this gas to meet the operational requirements of its transportation and storage customers and the requirements of its no-notice service customers.

Field Services

In 2011, the Company formed its Field Services subsidiary and transferred to it approximately 100 miles of gathering and transmission pipeline. In 2012, the Company transferred to Field Services a n additional 240 miles of pipeline and two compressor stations. Field Services is developing gathering and processing capabilities in south Texas and Pennsylvania.

Advisors' Opinion:

• [By Robert Rapier]

  There are at least three areas of opportunity for MLP investors resulting from this surge in US gas production. The first, and safest avenue of profit is in partnerships that are building out natural gas infrastructure to connect major gas-producing areas like the Marcellus Shale to major population centers, or to terminals that are being built to export liquefied natural gas (LNG). The list of partnerships involved in transporting natural gas is long, but includes such names as Energy Transfer Equity (NYSE: ETE), Enterprise Products Partners (NYSE: EPD), Kinder Morgan Energy Partners (NYSE: KMP), and B! oardwalk ! Pipeline Partners (NYSE: BWP). These partnerships tend to yield in the 3-6% range, and for the most part have relatively stable distributions (BWP being a notable recent exception with a drastic distribution cut earlier this year.)

• [By Robert Rapier]

  The worst performer in the first half was Oxford Resource Partners (NYSE: OXF), a coal producer that suspended its distribution more than a year ago and has seen its unit price continue to decline. It is down 31.5 percent in 2014. Boardwalk Pipeline Partners (NYSE: BWP) saw the second worst decline in the first half of 2014 after announcing a distribution cut of more than 80 percent. BWP saw its unit price plunge by 46 percent in a single trading session. It has since recovered somewhat, but is down 28.8 percent year-to-date.

• [By Sean Williams]

  Do investors have a reason to worry?

  Of the three stocks listed above Loews is likely the shakiest in terms of current fundamentals, but its long-term outlook continues to remain intact. Loews has sizable investment stakes in a handful of other companies, one of which is Boardwalk Pipeline Partners (NYSE: BWP  ) . Boardwalk's dividend had been one of the many factors fueling Loews' profitability. But in February, Boardwalk and majority holder Loews chose to slash its dividend by around 80% due to a weaker outlook in the natural gas market. This shaved a sizable chunk off Loews' profit forecast. Thankfully, its hotel operations and insurance business have been performing well, delivering more than enough cash flow to keep investors calm. In the near term it's possible Loews could struggle a bit, but over the long run its diversity should chase away most pessimists.

  Google
  Why are short-sellers avoiding Google?

source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-transportation-stocks-for-2015-2.html

Top 10 New Stocks To Buy Right Now

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines include new buy ratings for IBM (NYSE: IBM  ) and Toyota Motor (NYSE: TM  ) . But it's not all good news, so let's start off with a look at why one analyst is ...

Pulling the plug on Netflix
Stock markets are up this morning, but over at Netflix (NASDAQ: NFLX  ) , all investors are seeing is a static. Thanks in part to an initiation at "underweight" by Evercore Partners today, Netflix shares are sitting out the rally, and actually are down a fraction of a percent in late morning trading.

Why? In a word: competition. Evercore worries that even if it was the top dog and first mover in streaming video, the market is big enough to support more than one major player. If Netflix has to contend with one or more rivals, it will have to bid higher prices to license content from creators. This will raise the company's cost of business. Meanwhile, price competition on the delivery end will prevent the company from passing higher content costs on to consumers. Thus, Netflix will see its profit margins squeezed on both ends.

Top 10 Canadian Stocks To Buy For 2015: Vestas Wind Systems A/S (VWS)

Vestas Wind Systems A/S is a Denmark-based company active within the wind power industry. The Company operates within four business areas: Finance, Sales, Manufacturing & Global Sourcing, and Technology & Service Solutions. The Finance business area focuses on business support services. The Sales business area is divided into six geographical units: Americas, Asia Pacific & China, Central Europe, Mediterranean, Northern Europe and Offshore. The Manufacturing & Global Sourcing business area is engaged in the manufacturing of assembly, blades, components, controls and generators. The Technology & Service Solutions business area is responsible for the engineering solutions, platform and product management, as well as service engineering, among others. As of December 31, 2012, the Company operated globally through a network of subsidiaries located in Denmark, Germany, Italy, China, the United States, Spain, Estonia, Sweden and Norway. Advisors' Opinion:

• [By Pato Kehoe]

  Within the power infrastructure segment, GE is especially keen on advancing in clean-energy products, such as gas and wind turbines. Wind turbines have contributed significantly to generating a solid competitive advantage, even allowing the firm to surpass the Danish industry giant Vestas Wind Systems (VWS), thanks to superior customer care and manufacturing expertise. Hence, the road seems paved for continued success in this new industry sector, which is bound to continue growing as clean energy becomes more popular.

• [By Tom Stoukas]

  Vestas Wind Systems A/S (VWS) surged 11 percent to 66.30 kroner, its highest price since February 2012. Credit Suisse Group AG raised the world�� biggest wind-turbine maker to neutral from underperform, citing benefits from cost cuts.

Top 10 New Stocks To Buy Right Now: HyperSolar Inc (HYSR)

Hypersolar, Inc., incorporated on February 18, 2009, is developing renewable hydrogen using sunlight and any source of water, including seawater and wastewater. Unlike hydrocarbon fuels, such as oil, coal and natural gas, where carbon dioxide and other contaminants are released into the atmosphere when used, hydrogen fuel usage produces pure water as the only byproduct. The Company�� technology includes HyperSolar H2Generator. Its nano-size particle is designed to mimic photosynthesis and contains a solar absorber that generates electrons from sunlight, as well as integrated cathode and anode areas to readily split water and transfer those electrons to the molecular bonds of hydrogen.

The HyperSolar H2Generator consists of the following primary stages: Reactor Vessels, Hydrogen Compressor and Hydrogen Storage. The reactor vessels resemble transparent rectangular boxes containing water and billions of nanoparticles suspended in solution. When exposed to sunlight, hydrogen gas will bubble up into an air gap on top for separation and collection. Produced hydrogen gas will be compressed for space efficient storage. Hydrogen can be stored in compressed gas tanks or chemical canisters depending on the application. The HyperSolar H2Generator will be a self-contained renewable hydrogen production system that requires only sunlight and any source of water.

The Company competes with Air Products and Chemicals Inc. and Air Liquide.

Advisors' Opinion:

• [By John Udovich]

  Small cap hydrogen fuel stocks Hydrogenics Corporation (NASDAQ: HYGS), FuelCell Energy Inc (NASDAQ: FCEL), HyperSolar Inc (OTCMKTS: HYSR) and HydroPhi Technologies Group, Inc (OTCMKTS: HPTG) are some of the lesser known small caps that are�working with hydrogen fuel or hydrogen fuel cell related technology. I should say that small cap hydrogen stocks are not for risk adverse investors as there are considerable unanswered questions about hydrogen fuel related technology and whether it can be a viable green technology given the fueling infrastructure needed along with the�energy and expense involved in creating hydrogen�(Note: None of these small cap�stocks are profitable at ). But any new technology will pose the same types of risks for early stage investors���especially if its so-called green technology.�

Top 10 New Stocks To Buy Right Now: Osage Exploration and Development Inc (OEDV)

Osage Exploration and Development, Inc. (Osage) is an oil and natural gas exploration and production company with reserves and production in the country of Colombia and the state of Oklahoma. The Company�� pipeline is located in Colombia. The Companys focuses on developing its 28,000-acre Horizontal Mississippian block along the Nemaha Ridge in Logan County, Oklahoma, with their partners Slawson Exploration, and U.S. Energy Development Corp. The Company generates oil sales from its production operations in Colombia and in the state of Oklahoma and pipeline revenues from its Cimarrona property in Colombia. During the year ended December 31, 2011, the Company drilled two salt water disposal wells and commenced drilling the Wolfe#1-29H, the Company�� horizontal Mississippian well in Logan County, Oklahoma. In January 2012, the Company began drilling the Krittenbrink 2-36H, the Company�� second well in Logan County.

The Company�� subsidiary, Cimarrona LLC, owns a 9.4% interest in certain oil and gas assets in the Guaduas field, located in the Dindal and Rio Seco Blocks that consist of 21 wells, of which seven are producing, that covers 30,665-acres in the Middle Magdalena Valley in Colombia, as well as a pipeline with a capacity of approximately 30,000 barrels of oil per day. The Cimarrona property, but not the pipeline, is subject to an Ecopetrol Association Contract (the Association Contract) whereby the Company pays Ecopetrol S.A. (Ecopetrol) royalties of 20% of the oil produced.

The Company has acquired oil and gas leases in Logan County, Oklahoma targeting the Mississippian formation. The Mississippian formation is located on the Anadarko Shelf in northern Oklahoma and south-central Kansas. The top of this expansive carbonate hydrocarbon system is encountered between 4,000 and 6,000 feet and lies stratigraphically between the Pennsylvanian-aged Morrow Sand and the Devonian-aged Woodford Shale formations. The Mississippian formation reach 600 feet in gross thickness a! nd the targeted porosity zone is between 50 and 300 feet in thickness. The Company owns 100% of the working interest in certain producing oil and natural gas leases located in Osage County, Oklahoma (Hopper Property). The Property consists of 23 wells, 10 of which are producing wells, on 480 acres.

Advisors' Opinion:

• [By CRWE]

  Today, OEDV surged (+6.78%) up +0.08 at $1.26 with 39,220 shares in play thus far (ref. google finance Delayed: 11:56AM EDT August 22, 2013).

  Osage Exploration and Development, Inc. previously reported financial results for the three months ended June 30, 2013 and provided an update on field operations. For the quarter, the Company reported a 75.8% increase in revenues of $2.4 million compared to the same period in 2012, and operating income of $1.2 million versus a loss of $274,563 for the period ending June 30, 2012.

  Osage participated in drilling ten wells during the second quarter, bringing the total number of wells in which Osage has an interest to twenty-nine as of June 30, 2013. Additionally, the Company reported average daily production roughly in-line with first quarter production.

• [By CRWE]

  Today, OEDV surged (+1.96%) up +0.03 at $1.56 with 178,129 shares in play thus far (ref. google finance Delayed: 12:28PM EDT August 30, 2013).

  Osage Exploration and Development, Inc. previously reported preliminary production results on the Mallard 1-16H Horizontal Mississippian well in Logan County, Oklahoma. The well, located in Section 16-17N-3W, achieved a 24-hour peak initial production rate of 705 barrels of oil plus associated natural gas on an electric submersible pump and a 48/64��choke.

Top 10 New Stocks To Buy Right Now: Enertopia Corp (ENRT)

Enertopia Corp (Enertopia), incorporated on November 24, 2004, is engaged in medicinal marijuana business. The Company is diverse in its pursuit of business opportunities in several sectors, including: Medicinal Marijuana, Oil and Gas, Solar PV (Photovoltaic), Solar Thermal (Hot Water), Energy Retrofits and Recovery, and Solar powered Filtered Drinking Water.

The Company no longer has any material oil and gas resources. The Company operates in two segments: renewable energy, and mining exploration and developments, which are managed separately based on fundamental differences in their operations nature.

Advisors' Opinion:

• [By Peter Graham]

  What�� the Catch With Lexaria Corp? According to various disclosures, a transaction or transactions of $1k has or will occur to mention Lexaria Corp in various investment newsletters. Last Friday, Lexaria Corp announced it had closed its Private Placement financing announced on March 5 for gross proceeds of $1,272,000 ��higher than the originally announced $960,000 figure due to ��verwhelming demand.��Lexaria Corp will issue 10,600,000 common shares at US$0.12 and 10,600,000 full warrants that expire on September 21, 2016 with an exercise price of US$0.25. However, the company may also accelerate the expiry date of the warrants if the stock price trades above CAD$0.40 cents for 20 consecutive days at any time after 6 months and one day has elapsed. Otherwise and in early March, Lexaria Corp reported that its board of directors had decided to make a strategic entry into the medical marijuana business by way of an ��mportant Joint Venture��with Enertopia Corp (OTCQB: ENRT). Under the terms of the Agreement, Lexaria Corp had agreed to pay Enertopia 1 million restricted common shares in return for Enertopia's participation plus 500,000 restricted common shares ENRT�� Chairman in return for his participation on the Lexaria Advisory Board. Following the issuance of these shares, Lexaria Corp will have a total of 18,431,452 shares issued and outstanding and 21,256,452 shares fully diluted. A quick look at Lexaria Corp�� financials reveals revenues of $160k (most recent reported quarter), $241k, $251k and $253k for the past four quarters along with net losses of $102k (most recent reported quarter), $126k, $58k and $48k. At the end of last January, Lexaria Corp had $66k in cash to cover $1,415k in current liabilities and $59k in other liabilities. So aside from the income statement, investors might want to look more closely at Lexaria Corp�� financing terms.

Top 10 New Stocks To Buy Right Now: Extreme Biodiesel Inc (XTRM)

Extreme Biodiesel Inc., formerly Book Merge Technology, Inc., incorporated on February 28, 2008, is engaged in manufacturing of home biodiesel processors. The Company focuses to produce alternative fuel. The Company has a bio diesel refinery and factory for refining diesel oil and manufacturing bio diesel processors. On October 11, 2010, the Company acquired a 51% interest in EGT. on October 11, 2010, the reverse acquisition was effected. On March 31, 2011, the Company completed the acquisition of EGT.

The Company�� products include standard extractor, extreme extractor, extreme mini-refinery, extreme purification system, titration kit, dispensing pump with meter and oil collection pump. The standard extractor is a biodiesel processor, which requires a water-wash process to purify the biodiesel. Extreme extractor is a waterless purification system. The Mini Refinery is the waterless system, which can make 600 gallons of quality biodiesel per day.

Advisors' Opinion:

• [By Peter Graham]

  Small cap resource or green stocks Paradigm Resource Management Corp (OTCMKTS: PRDC), Extreme Biodiesel Inc (OTCMKTS: XTRM) and Pan Global Corp (OTCMKTS: PGLO) have all been getting some attention lately thanks in part to a few paid stock promotions. However, two of these small cap appear to be the subject of minimal paid promotion activity, but even a small paid promotion or investor relations campaign can increase a stock�� volatility. So do these three small cap resource or green stocks have what it takes to deliver some Christmas cheer for investors and traders alike? Here is a quick reality check:

Top 10 New Stocks To Buy Right Now: Solar Thin Films Inc (SLTZ)

Solar Thin Films, Inc. is engaged in the business of designing, manufacturing and installation of thin-film amorphous silicon (a-Si) photovoltaic manufacturing equipment. The equipment is used in plants that produce photovoltaic thin-film a-Si solar panels or modules. The Company operates through its wholly owned subsidiary, Kraft Elektronikai Zrt (Kraft). Kraft is engaged in the design, development, manufacture, and installation of a-Si photovoltaic manufacturing equipment. The primary buyers of photovoltaic thin-film manufacturing equipment are businesses, as well as investment partnerships, engaged in the production of photovoltaic thin-film modules. In May 2010, the Company acquired Atlantis Solar LLC. In May 2013, Solar Thin Films Inc acquired Quality Resource Technologies Inc. In October 2013, Solar Thin Films Inc announced the sale of all of its ownership stake of Hungarian subsidiary, Kraft, R.t. (Kraft), to GJR Collectibles LLC.

Kraft has been providing equipment that is incorporated into a single manufacturing line capable of manufacturing a-Si solar modules that produce approximately 5megawatt (MW) of solar power annually. The Company focuses, directly and through joint ventures or alliances with other companies or governmental agencies, to sell equipment for and participate financially in solar power facilities using thin film a-Si solar modules or metallurgical and other crystalline solar modules as the power source to provide electricity to municipalities, businesses and consumers.

The Company competes with Applied Materials and Oerlikon.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Alliance Creative Group Inc (OTCMKTS: ACGX), Dale Jarrett Racing Adventure Inc (OTCMKTS: DJRT), Inscor Inc (OTCMKTS: IOGA) and Solar Thin Films Inc (OTCMKTS: SLTZ) have all been getting some attention lately in various investment newsletters and it should come as no surprise that two out of four of these stocks have been the subject of paid promotions ��which tend to benefit traders. However, two out of four of these stocks also have pretty good financials for being small cap OTC stocks and that might make them attractive to investors with a long term time horizon. So which of these stocks might make traders some profits in the short term and investors some profits over the longer term? Here is a closer look to help you decide:

Top 10 New Stocks To Buy Right Now: Ceres Inc (CERE)

Ceres, Inc. (Ceres), incorporated in March 1996, is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks that can enable the large-scale replacement of petroleum and other fossil fuels. The Company�� large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomass sorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has started marketing sweet sorghum seeds in Brazil and has sold switchgrass and high biomass sorghum seeds in the United States under its brand, Blade Energy Crops (Blade). In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.

The Company generates its revenues from government grants, research and development collaboration agreements and from product sales. Product sales primarily consists of sales of seeds. Collaborative research revenues consist of payments for research and development activities for specific projects. Government grant revenues consist of payments from government entities. Ceres markets its seeds and traits directly to ethanol mills, utilities, independent power producers, cellulosic biofuel companies, individual growers and grower cooperatives. It also works with technology providers and other market participants, such as equipment manufacturers and enzyme or fermentation technology companies. The Company markets its products to biorefineries and biopower facilities.

Ceres�� activities in cellulosic biofuels encompass a range of activities, including field trials, co-evolution agr! eements, and commercial sales. Its products have been tested in the conversion processes of EdeniQ, Inc., Choren USA LLC, Gruppo M&G, ICM, Inc., and UOP, LLC (a Honeywell company), among others. The Company has also conducted joint trials with, or sold seed to, AGCO Corporation, EdeniQ, Inc. and Hawai�� BioEnergy, LLC, among others. It has begun collaboration with Valero Services, Inc. to further evaluate feedstock supply strategies with energy crops. Ceres also works with refining technology companies to optimize feedstock for their refining processes. These collaborators include Novozymes North America, Inc. and ThermoChem Recovery International, Inc.

Drop-in Products

The Company�� products are drop-in solutions as they can be planted, harvested and processed using existing agricultural equipment with little or no modification and are being developed to be drop-in for all conversion technologies using sugarcane or biomass feedstocks, facilitating their rapid adoption. In collaboration with Boa Vista/Nova Fronteira, which is a joint venture of ethanol producers Grupo Sao Martinho, S.A. and Petrobras Biofuels, the Company has completed a commercial-scale trial on approximately 250 hectares of its sweet sorghum, which was planted and harvested using existing planting and harvesting equipment, fermented into ethanol without retrofitting or altering the existing mill and the remaining biomass combusted for electricity production, using existing boilers. It has also conducted smaller trials using its other energy crops with numerous industry participants engaged in cellulosic biofuels and biopower production. The Company�� products have been tested in the conversion processes of Amyris Biotechnologies, Inc., Choren USA LLC, EdeniQ, Inc., Gruppo M&G, ICM, Inc., Novozymes North America, Inc., ThermoChem Recovery International, Inc. and UOP, LLC (a Honeywell company), among others. DuPont Danisco Cellulosic Ethanol LLC (DDCE) also plans to validate the Company�� products in th! eir conve! rsion process.

Sweet Sorghum

Sweet sorghum is a type of sorghum that accumulates free sugars in its stalk. It is sown by seed, and requires less water and nitrogen fertilizer to grow to harvestable maturity. Sweet sorghum plants can be harvested in 90 to 140 days after sowing. Because sweet sorghum is an annual crop, multiple harvests or crop rotations may be possible during the season.

High Biomass Sorghum

High biomass sorghum is a type of sorghum, which is primarily developed for biomass yield. As such, high biomass sorghum is suited for the generation of renewable electric power and the creation of cellulosic biofuels. High biomass types are seed propagated, and requires less water and nitrogen fertilizer. As an annual crop, sorghum is harvested the year it is planted. This provides bioenergy facilities with a growing and flexible source of biomass, and a complementary feedstock to perennials, such as sugarcane or switchgrass. The Company�� ES 5200 and ES 5201 products contains its Skyscraper trait. These hybrids, developed through its partnership with Texas A&M University, are designed for single-cut production systems.

Switchgrass

Switchgrass is a perennial grass indigenous to North America that offers high biomass yield potential. It requires less water and nitrogen fertilizer, and can grow under semi-arid conditions. Switchgrass is seed propagated. As a perennial, switchgrass is not harvested for sale during the first year when the crop is being established. A properly managed stand of switchgrass may persist for a decade. During the year ended December 31, 2010, it introduced three products: EG 1101, EG 1102 and EG 2101. These high-yielding varieties is developed through its partnership with The Samuel Roberts Noble Foundation.

Miscanthus

Miscanthus x giganteus is a tall perennial grass that grows well in cooler climates. It is vegetatively propagated. It has been used as an energy crop on ! a small s! cale across Europe. The Miscanthus genus includes several perennial species that has energy crops. The variety adopted in the United States and Europe, miscanthus x giganteus, is a sterile hybrid of M. sinensis and M. sacchariflorus. This miscanthus hybrid requires about the same water as corn, but up to two-thirds less nitrogen depending on crop management practices. As a perennial crop, miscanthus is not harvested for sale during the first year when the crop is being established. Ceres is also working on extending the region of adaptation. To these ends, the Company is collaborating with the Institute of Biological, Environmental, and Rural Sciences of Aberystwyth University in Wales, the United Kingdom.

The Company competes with Advanta India Limited, The Dow Chemical Company, Monsanto Company, Pioneer Hi-Bred (DuPont), KWS and Syngenta.

Advisors' Opinion:

• [By Maxx Chatsko]

  Shares of energy crop developer Ceres (NASDAQ: CERE  ) surged more than 100% from the opening bell Monday to early trading on Thursday. In fact, over one-third of the total outstanding shares traded hands on Thursday. Even with the move the company is trading for "only" $100 million. With some of the biggest names in industrial biotech on its side -- such as Syngenta (NYSE: SYT  ) , Petrobras, Amyris, Valero, Novozymes, Gruppo M&G, and Mascoma, to name a few -- this must be a good buy right? Not so fast.

• [By Roberto Pedone]

  Another renewable energy player that looks ready to trigger a big breakout trade is Ceres (CERE), which sells seeds to produce renewable biomass feedstocks that can enable the large-scale replacement of petroleum and other fossil fuels. This stock has been hammered by the bears so far in 2013, with shares off sharply by 66%.

  If you take a look at the chart for Ceres, you'll notice that this stock has just started to trend back above its 50-day moving average of $1.45 a share with heavy upside volume flows. Volume so far today has already registered over 1.15 million shares, which is well above its three-month average action of 670,538 shares. This spike back above its 50-day is now quickly pushing shares of CERE within range of triggering a big breakout trade.

  Traders should now look for long-biased trades in CERE if it manages to break out above some near-term overhead resistance levels at $1.67 to $1.68 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 670,538 shares. If that breakout hits soon, then CERE will set up to re-test or possibly take out its next major overhead resistance levels at $2 to $2.50 a share. Shares of CERE could even tag $3 if this breakout triggers with strong volume.

  Traders can look to buy CERE off any weakness to anticipate that breakout and simply use a stop that sits right below $1.40 a share. One could also buy CERE off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By James E. Brumley]

  Despite the fact that markets are right around breakeven levels for Wednesday, there are relatively few stocks that are up today, and even fewer that are up on strong volume. For the NYSE, 54% of its listed equities are in the red this morning, and 58% of the total volume seen so far has been bearish volume. That's what makes Ceres Inc. (NASDAQ:CERE) so interesting early Wednesday. As one of the few tickers that's not only up, but up on higher volume, CERE is a standout worth a closer look. And, that closer look reveals something even more compelling about the way things are coming together for this small cap stock.